Clinical Trial
February 6, 2018, Volume 137, Issue 6
JOURNAL:Circulation
Article Link

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
M .Kosiborod, CVD-REAL Investigators and Study Group.

KEYWORDS
SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

http://www.cbsmd.cn Contact us by cbs@cbsmd.cn

Copyright ⓒ CBSMD Nanjing China. All rights reserved.